ArticleFrontiers in chemistry2022

Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer.

Zi-Ying Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.